
Eli Lilly released phase 2b trial results comparing the investigational eloralintide-tirzepatide combo with tirzepatide 15 mg alone in patients with T2D and obesity.
Stopping medication errors in a busy pharmacy isn't an easy fix, but steps must be taken to lessen a serious problem.






